Skip to main content
Clinical Trials/CTRI/2017/08/009550
CTRI/2017/08/009550
Completed
Phase 4

A comparative study on efficacy of suprascapular nerve block versus subacromial steroid injection in shoulder impingement syndrome.

IPGMER SSKM Hospital0 sites70 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
IPGMER SSKM Hospital
Enrollment
70
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 6, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IPGMER SSKM Hospital

Eligibility Criteria

Inclusion Criteria

  • (1\) Clinically suggestive and USG and/or MRI confirming Neer Stage I \& II impingement.
  • (2\) Not sufficiently responding to conservative treatment over 8weeks.
  • (3\) Aged 20 to 60 years.
  • (4\) Pain defined as a score of 5 points or more on a 10\-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain).
  • (5\) Patient mentally sound enough to communicate and participate in the study and can understand the parameters well.

Exclusion Criteria

  • 1\. USG showing Rotator cuff tear.
  • 2\. Bleeding or clotting disorders.
  • 3\. Patients refusing intervention or participation.
  • 4\. The presence of another obvious associated cause for the pain (i.e., Primary osteoarthritis of glenohumeral joint, fracture, radiculopathy, myofascial pain, central neuropathic pain)
  • 5\. Severe motor weakness (muscle power of deltoid less than grade 2 on the manual muscle test).
  • 6\. Patients with Post myocardial infarction, Post stroke, Post mastectomy, prolonged immobilization.
  • 7\. The presence of an unstable medical condition or a known uncontrolled systemic disease, including cancer, diabetes, rheumatoid arthritis, endocrine disease,
  • major depression, schizophrenia, \& patients with persistent very high level of ESR \& CRP.
  • 8\. Patients with contraindications of steroid injections i.e. overlying soft tissue sepsis, bacteraemia, anatomic inaccessibility, uncooperative patient, uncontrolled bleeding diathesis etc.
  • 9\. Patients who got intra\-articular injection in shoulder within last six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials